(Q73516741)
Statements
Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a (English)
Perini P
Tiberio M
Sivieri S
Facchinetti A
Biasi G